Inventor
YAO YIHONG
US22 patents
⚠️ This page may combine multiple inventors who share the name “YAO YIHONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CELLULAR BIOMEDICINE GROUP HK LTD
6 patentsUS11439665B2Sep 13, 2022
Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof
CELLULAR BIOMEDICINE GROUP HK LTD8 citations85
US11472858B2Oct 18, 2022
Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof
CELLULAR BIOMEDICINE GROUP HK LTD7 citations84
US11207349B2Dec 28, 2021
Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof
CELLULAR BIOMEDICINE GROUP HK LTD7 citations83
US11066457B2Jul 20, 2021
Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof
CELLULAR BIOMEDICINE GROUP HK LTD8 citations83
US11498973B2Nov 15, 2022
BCMA-targeted chimeric antigen receptor as well as preparation method therefor and application thereof
CELLULAR BIOMEDICINE GROUP HK LTD1 citations60
US11142581B2Oct 12, 2021
BCMA-targeted chimeric antigen receptor as well as preparation method therefor and application thereof
CELLULAR BIOMEDICINE GROUP HK LTD1 citations60
ABELZETA INC
5 patentsUS12448432B2Oct 21, 2025
Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof
ABELZETA INC1 citations73
US12311022B2May 27, 2025
Bispecific chimeric antigen receptors targeting CD20 and BCMA
ABELZETA INC2 citations73
US12458667B2Nov 4, 2025
Bispecific chimeric antigen receptors targeting CD20 and BCMA
ABELZETA INC1 citations63
US12583903B2Mar 24, 2026
Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof
ABELZETA INC0 citations61
US12338494B2Jun 24, 2025
Reagent and method for fluorescence quantitative real-time PCR detection of RCL
ABELZETA INC0 citations59
CELLULAR BIOMEDICINE GROUP INC
4 patentsUS11633430B2Apr 25, 2023
Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof
CELLULAR BIOMEDICINE GROUP INC7 citations84
US11618778B2Apr 4, 2023
Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof
CELLULAR BIOMEDICINE GROUP INC7 citations84
US11608369B2Mar 21, 2023
Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof
CELLULAR BIOMEDICINE GROUP INC7 citations84
US11697848B2Jul 11, 2023
Reagent and method for fluorescence quantitative real-time PCR detection of RCL
CELLULAR BIOMEDICINE GROUP INC0 citations59
MEDIMMUNE LLC
3 patentsUS9493570B2Nov 15, 2016
Fixed dosage regimens for anti-type I interferon receptor (IFNAR) antibodies
MEDIMMUNE LLC8 citations82
US10775388B2Sep 15, 2020
Methods of using antibodies to determine periostin levels in a sample
MEDIMMUNE LLC1 citations55
US9862762B2Jan 9, 2018
Monoclonal antibodies which bind human periostin
MEDIMMUNE LLC0 citations47